109790 ⎘
dsDNA viruses; Details; Herpesviridae; Cytomegalovirus, e.g. human herpesvirus 5; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Composition and Use Method Therefor
#2UNIVERSAL T CELL-BASED, CMV-VECTORED VACCINE FOR INFLUENZA
#3GENE THERAPY FOR CEROID LIPOFUSCINOSES
#4CONJUGATE POLYPEPTIDES AND VACCINES FOR INDUCING IMMUNE RESPONSES
#5SELECTIVE FUNCTIONAL ENHANCEMENT OF STEM CELLS AND OR THEIR GENETIC MATERIAL, WITH GENE TRANSFECTION FOR SHORT-AND LONG-TERM TREATMENT OF AGE-RELATED DISEASE STATES
#6STEM CELL AND SOMATIC CELL REPROGRAMMING WITH GENE ENHANCED STEM CELLS TO RESTORE AGE RELATED FOR PHYSICAL FUNCTIONS TO EXTEND LONGEVITY
#7MODIFIED VIRUS-LIKE PARTICLES OF CMV
#8ENGINEERED MURINE CYTOMEGALOVIRUS-DERIVED TOOL VIRUS, METHOD OF PRODUCING THE SAME AND APPLICATIONS THEREOF
#9METHODS FOR PRODUCING CMV VECTORS
#10SINGLE-VECTOR GENE CONSTRUCT COMPRISING INSULIN AND GLUCOKINASE GENES
#11HIV VACCINES AND METHODS OF USING
#12A MURINE CYTOMEGALOVIRUS VACCINE VECTOR FOR ADMINISTRATION IN A NON-MOUSE SUBJECT
#13DRUG FOR TREATING AFTEREFFECTS OF NOVEL CORONAVIRUS INFECTION
#14CYTOMEGALOVIRUS VECTORS AND METHODS OF USE
#15Use Of Liposomes To Deliver A Protein And A Gene Encoding The Protein To A Live Cell
#16HIV VACCINES AND METHODS OF USING
#17CMV-BASED HUMAN PAPILLOMAVIRUS VACCINES
#18METHOD FOR EFFICIENTLY INFECTING HUMAN NATURAL KILLER CELLS AND OTHER IMMUNE CELLS WITH PSEUDOVIRUS
#19RECOMBINANT HCMV VECTORS AND USES THEREOF
#20CCL20 PROMOTER-REGULATED GENE EXPRESSION
#21TUBERCULOSIS VACCINES
#22EXPRESSION VECTORS, BACTERIAL SEQUENCE-FREE VECTORS, AND METHODS OF MAKING AND USING THE SAME
#23COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS
#24Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis
#25VECTOR SYSTEMS AND METHODS OF USING SAME
#26COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS
#27GENETIC THERAPY FOR GLAUCOMA AND OPTIC NEUROPATHIES
#28CMV VECTORS AND USES THEREOF
#29GENE THERAPY FOR CEROID LIPOFUSCINOSES
#30Development of optimized recombinant expression construct
#31CONJUGATE POLYPEPTIDES AND VACCINES FOR INDUCING IMMUNE RESPONSES
#32MAMMALIAN EXPRESSION VECTORS
#33MODULATION OF T CELL RESPONSES BY UL18 OF HUMAN CYTOMEGALOVIRUS
#34SYSTEMS AND METHODS FOR GENE THERAPY VIA ADMINISTRATION OF GENETICALLY MODIFIED VIRAL VECTORS
#35HIV vaccines and methods of using
#36OPTIMIZED SUMF1 GENES AND EXPRESSION CASSETTES AND THEIR USE
#37INTRINSIC SYSTEM FOR VIRAL VECTOR TRANSGENE REGULATION
#38GENE THERAPY USING GENETICALLY MODIFIED VIRAL VECTORS
#39Inducible expression from transposon-based vectors and uses
#40HIGH-PRECISION BASE EDITORS
#41Compositions and Methods for Improving Base Editing
#42ISL1 and LHX3 VECTOR
#43Human cytomegalovirus comprising exogenous antigens
#44Recombinant cytomegalovirus vectors as vaccines for tuberculosis
#45Use Of Liposomes To Deliver A Protein And A Gene Encoding The Protein To A Live Cell
#46Method for inhibiting STAT3 activity comprising administering Ssu72
#47Potent and balanced bidirectional promoter
#48Nucleic acids encoding Zika virus-like particles and their use in Zika virus vaccines and diagnostic assays
#49CMV VECTORS AND USES THEREOF
#50GENE THERAPY FOR ALZHEIMER`S DISEASE
#51HIV vaccines comprising one or more population episensus antigens
#52HIV vaccines comprising one or more population episensus antigens
#53Methods and compositions useful in generating non canonical CD8+ T cell responses
#54CMV VECTORS COMPRISING MICRORNA RECOGNITION ELEMENTS
#55PSMA-based molecular-genetic reporter system
#56METHODS AND COMPOSITIONS FOR EXPRESSION OF POLYPEPTIDES IN A CELL
#57Gene therapy for ceroid lipofuscinoses
#58Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
#59Single-vector gene construct comprising insulin and glucokinase genes
#60METHOD OF IDENTIFYING PEPTIDE EPITOPES, MOLECULES THAT BIND SUCH EPITOPES AND RELATED USES
#61Compositions featuring an attenuated newcastle disease virus and methods of use for treating neoplasia
#62Human cytomegalovirus comprising exogenous antigens
#63CMV PROMOTER AND METHOD FOR PRODUCTION OF POLYPEPTIDES
#64Promoter with an enriched Cytosine-Guanine dinucleotide region, vectors, cellular lines, method for producing recombinant protein
#65Nucleic acids encoding zika virus-like particles and their use in zika virus vaccines and diagnostic assays
#66Potent and balanced bidirectional promoter
#67CMV glycoproteins and recombinant vectors
#68ONCOLYTIC VIRUSES COMPRISING esRAGE AND METHODS OF TREATING CANCER
#69Inducible expression from transposon-based vectors and uses
#70Recombinant HCMV and RHCMV vectors and uses thereof
#71HIGH EFFICIENCY, HIGH THROUGHPUT GENERATION OF GENETICALLY MODIFIED NON-HUMAN MAMMALS BY MULTI-CYCLE ELECTROPORATION OF CAS9 PROTEIN
#72Hybrid promoter and uses thereof
#73Targeted expression of chloride channels and methods of use thereof
#74Turkey herpesvirus vectored recombinant containing avian influenza genes
#75Human cytomegalovirus comprising exogenous antigens
#76DNA recombination
#77Transgenic legumes
#78Method of preventing rheumatoid arthritis comprising administering polynucleotide encoding SSU72
#79Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
#80Cytomegalovirus vectors enabling control of T cell targeting
#81Methods and compositions for expression of polypeptides in a cell
#82CYTOMEGALOVIRUS-BASED VACCINE EXPRESSING EBOLA VIRUS GLYCOPROTEIN
#83Recombinant cytomegalovirus vectors as vaccines for tuberculosis
#84Single-vector gene construct comprising insulin and glucokinase genes
#85CMV glycoproteins and recombinant vectors
#86HIV vaccines comprising one or more population episensus antigens
#87Turkey herpesvirus vectored recombinant containing avian influenza genes
#88Vaccine comprising beta-herpesvirus
#89PSMA-based molecular-genetic reporter system
#90REPORTER VECTOR FOR EVALUATING CHARACTERISTICS OF SUBJECT CELL, ASSAY KIT, PROCEDURE AND DEVICE
#91Diagnosis And Treatment Of Cancers With MicroRNA Located In Or Near Cancer-Associated Chromosomal Features
#92CMV vectors comprising microRNA recognition elements
#93Expression cassette and vector comprising Alzheimer's disease-related mutant genes and cell line transformed by means of same
#94METHODS AND COMPOSITIONS FOR EXPRESSION OF POLYPEPTIDES IN A CELL
#95Method of enhancing translation of foreign genes in plants
#96EUKARYOTIC EXPRESSION VECTORS RESISTANT TO TRANSGENE SILENCING
#97CMV promoter and method for production of polypeptides
#98COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASES USING FOXP3
#99Compositions featuring an attenuated Newcastle disease virus and methods of use for treating neoplasia
#100Recombinant HCMV and RHCMV vectors and uses thereof
#101Tripartite cancer theranostic nucleic acid constructs
#102Replication-competent adenoviral vectors
#103Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin
#104Cytomegalovirus vectors enabling control of T cell targeting
#105Compositions and methods of use thereof for identifying anti-viral agents
#106EXPRESSION VECTORS COMPRISING THE MCMV IE2 PROMOTER
#107Replicating recombinant adenovirus vectors, compositions, and methods of use thereof
#108Replication-competent adenoviral vectors
#109TURKEY HERPESVIRUS VECTORED RECOMBINANT CONTAINING AVIAN INFLUENZA GENES
#110CMV glycoproteins and recombinant vectors
#111CMV glycoproteins and recombinant vectors
#112Viral particle released after infection of mammalian cells by human cytomegalovirus (HCMV) containing a fusion protein and use thereof
#113Recombinant HCMV and RHCMV vectors and uses thereof
#114NOVEL POLYNUCLEOTIDE MOLECULES FOR ENHANCED GENE EXPRESSION
#115CYTOMEGALOVIRUS INTRON A FRAGMENTS
#116Eukaryotic expression vectors resistant to transgene silencing
#117Expression vectors comprising the mCMV IE2 promoter
#118RECOMBINANT VECTOR CONTAINING INFECTIOUS HUMAN CYTOMEGALOVIRUS GENOME WITH PRESERVED WILD-TYPE CHARACTERISTICS OF CLINICAL ISOLATES
#119Therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin
#120DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES
#121DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER ASSOCIATED CHROMOSOMAL FEATURES
#122Turkey herpesvirus vectored recombinant containing avian influenza genes
#123RECOMBINANT HUMAN CYTOMEGALOVIRUS AND VACCINES COMPRISING HETEROLOGOUS ANTIGENS
#124Turkey herpesvirus vectored recombinant containing avian influenza genes
#125Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine Vectors
#126Recombinant Human Cytomegalovirus And Vaccines Comprising Heterologous Antigens
#127Expression vectors comprising the mCMV IE2 promoter
#128Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
#129Methods and vectors for controlling gene expression
#130Replication-competent adenoviral vectors
#131Diagnosis and treatment of cancers with microRNA located in or near cancer associated chromosomal features
#132Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates
#133Attenuated protein expression vectors and associated methods